Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy

被引:54
作者
Qua, C. S.
Wong, C. H.
Gopala, K.
Goh, K. L. [1 ]
机构
[1] Univ Malaya, Fac Med, Dept Med, Div Gastroenterol, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Fac Med, Dept Otorhinolaryngol, Kuala Lumpur 50603, Malaysia
关键词
D O I
10.1111/j.1365-2036.2006.03185.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Gastro-oesophageal reflux is thought to cause chronic laryngitis through laryngopharyngeal reflux. Response of laryngitis to treatment with acid-suppressive therapy supports this causal link. Aim To determine the prevalence of gastro-oesophageal reflux disease in patients with chronic laryngitis and response to proton-pump inhibitor therapy. Methods Patients with chronic laryngitis were recruited. The frequency and severity of reflux and laryngeal symptoms were scored and laryngitis graded by laryngoscopy. All patients underwent esophagogastroduodenoscopy and 24-h ambulatory pH monitoring before receiving lansoprazole 30 mg b.d. for 8 weeks. Results The prevalence of gastro-oesophageal reflux disease was 65.6% (21 of 32). Based on positive pH test, the prevalence was 25% (eight of 32). The change in laryngeal symptom score and laryngitis grade was significantly higher in GERD compared with non-GERD patients (P = 0.010 for both). The proportion of patients with marked/moderate improvement in laryngeal symptoms were significantly higher in patients with reflux (14 of 21, 67%) compared to those without reflux (two of 11, 18%; P = 0.026). Conclusions The prevalence of gastro-oesophageal reflux disease amongst our patients with chronic laryngitis was high. The response to treatment with proton-pump inhibitors in patients with reflux disease compared to those without underlined the critical role of acid reflux in a subset of patients with chronic laryngitis.
引用
收藏
页码:287 / 295
页数:9
相关论文
共 36 条
[31]   Treatment of chronic posterior laryngitis with esomeprazole [J].
Vaezi, MF ;
Richter, JE ;
Stasney, CR ;
Spiegel, JR ;
Iannuzzi, RA ;
Crawley, JA ;
Hwang, C ;
Sostek, MB ;
Shaker, R .
LARYNGOSCOPE, 2006, 116 (02) :254-260
[32]  
WIENER GJ, 1989, AM J GASTROENTEROL, V84, P1503
[33]   Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis [J].
Williams, RBH ;
Szczesniak, MM ;
Maclean, JC ;
Brake, HM ;
Cole, IE ;
Cook, IJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (05) :777-785
[34]  
Wo JM, 1997, AM J GASTROENTEROL, V92, P2160
[35]   Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy [J].
Wong, CH ;
Chua, CJ ;
Liam, CK ;
Goh, KL .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (09) :1321-1327
[36]   Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux [J].
Ylitalo, R ;
Lindestad, PÅ ;
Ramel, S .
LARYNGOSCOPE, 2001, 111 (10) :1735-1741